Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma-Reference-Cited by-同舟云学术

Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma

Published:2017-02 Issue:2 Volume:19 Page:235-249
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Oelsner Sarah,Friede Miriam E.,Zhang Congcong,Wagner Juliane,Badura Susanne,Bader Peter,Ullrich Evelyn,Ottmann Oliver G.,Klingemann Hans,Tonn Torsten,Wels Winfried S.

Funder

Deutsche Forschungsgemeinschaft

LOEWE Center for Cell and Gene Therapy Frankfurt

Georg-Speyer-Haus

Stiftung Polytechnische Gesellschaft, Frankfurt am Main to Sarah Oelsner

German Federal Ministry of Health

Ministry of Higher Education, Research and the Arts of the State of Hessen

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference50 articles.

1. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci Transl Med,2011

2. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N Engl J Med,2013

3. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci Transl Med,2013

4. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study;Cruz;Blood,2013

5. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced non-viral gene delivery via calcium phosphate/DNA co-precipitates with low-voltage pulse electroporation in NK-92 cells for immunocellular therapy;APL Bioengineering;2024-08-06

2. The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity;Cancers;2024-07-22

3. IL-27-engineered CAR.19-NK-92 cells exhibit enhanced therapeutic efficacy;Cytotherapy;2024-06

4. Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-09

5. Nanobody-based CAR NK cells for possible immunotherapy of MICA+ tumors;PNAS Nexus;2024-04-30